Ingevity Corp (NGVT)

Return on equity (ROE)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands -5,400 127,000 177,200 201,500 211,600 225,300 145,700 130,200 118,100 134,800 208,900 184,800 181,400 179,700 169,700 206,300 183,700 181,500 171,100 161,000
Total stockholders’ equity US$ in thousands 631,400 718,700 714,100 725,700 698,300 633,900 654,300 686,100 673,800 644,500 688,500 661,100 642,100 617,000 522,900 502,100 530,800 443,300 400,700 358,700
ROE -0.86% 17.67% 24.81% 27.77% 30.30% 35.54% 22.27% 18.98% 17.53% 20.92% 30.34% 27.95% 28.25% 29.12% 32.45% 41.09% 34.61% 40.94% 42.70% 44.88%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-5,400K ÷ $631,400K
= -0.86%

Ingevity Corp's return on equity (ROE) has shown fluctuations over the past eight quarters, ranging from -0.86% to 35.54%.

In Q1 2022, the ROE was at a relatively high level of 18.98%. The ratio increased further in the following quarters, reaching the peak of 35.54% in Q3 2022. This indicates that the company was generating substantial profits relative to shareholders' equity during that period.

However, the ROE started declining from Q4 2022 and continued to decrease through the first three quarters of 2023. Most notably, the ROE turned negative in Q4 2023 at -0.86%, signifying that the company's net income was insufficient to cover shareholders' equity.

The declining trend in ROE could suggest potential issues with the company's profitability and efficiency in generating returns for shareholders. Investors and analysts may want to further investigate the reasons behind the decreasing ROE and evaluate the company's strategies for improving profitability in the future.


Peer comparison

Dec 31, 2023